209 related articles for article (PubMed ID: 19004556)
1. The impact of selective publication on clinical research in pain.
Rowbotham MC
Pain; 2008 Dec; 140(3):401-404. PubMed ID: 19004556
[No Abstract] [Full Text] [Related]
2. Industry-sponsored clinical research: a broken system.
Angell M
JAMA; 2008 Sep; 300(9):1069-71. PubMed ID: 18768418
[No Abstract] [Full Text] [Related]
3. Ghostwriters, data manipulation and dollar diplomacy: how drug companies pull the strings in clinical research.
Berger E
Ann Emerg Med; 2008 Aug; 52(2):137-9. PubMed ID: 18672488
[No Abstract] [Full Text] [Related]
4. Conflicting interests: the evolution of an issue.
Healy D
Monash Bioeth Rev; 2004 Oct; 23(4):8-18. PubMed ID: 15688509
[TBL] [Abstract][Full Text] [Related]
5. Research dishonesty and conflict of interest.
Frizelle F
N Z Med J; 2002 Dec; 115(1167):U270. PubMed ID: 12552259
[No Abstract] [Full Text] [Related]
6. Practical and political problems with a global research tax.
Resnik DB
Am J Bioeth; 2010 Jun; 10(6):44-5. PubMed ID: 20526971
[No Abstract] [Full Text] [Related]
7. Unravelling industry bias in clinical trials.
Gluud LL
Pain; 2006 Apr; 121(3):175-176. PubMed ID: 16513277
[No Abstract] [Full Text] [Related]
8. Independent medical research.
van der Meer JW; de Gier AM; van Swaaij WP; Katan MB
Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759
[No Abstract] [Full Text] [Related]
9. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
Tereskerz PM
Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
[No Abstract] [Full Text] [Related]
10. Correspondence (letter to the editor): Trend gives cause for concern.
Maier C; Zenz M
Dtsch Arztebl Int; 2010 Sep; 107(38):670-1; author reply 673-4. PubMed ID: 20953257
[No Abstract] [Full Text] [Related]
11. Research funding, conflicts of interest, and the meta-methodology of public relations.
Rampton S; Stauber J
Public Health Rep; 2002; 117(4):331-9. PubMed ID: 12477914
[No Abstract] [Full Text] [Related]
12. The perverse consequences of a proposed global tax on research.
MacDonald C; Walton N
Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972
[No Abstract] [Full Text] [Related]
13. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward.
Samson K
Ann Neurol; 2010 Mar; 67(3):A7-A10. PubMed ID: 20373337
[No Abstract] [Full Text] [Related]
14. Drug research: marketing before evidence, sales before safety.
Klemperer D
Dtsch Arztebl Int; 2010 Apr; 107(16):277-8. PubMed ID: 20467552
[No Abstract] [Full Text] [Related]
15. [Conflicts of interest--an evidence-based approach].
Slørdal L; Eggen AE; Rygnestad T
Tidsskr Nor Laegeforen; 2012 Jun; 132(11):1358-60. PubMed ID: 22717864
[No Abstract] [Full Text] [Related]
16. Achieving greater independence from commercial influence in research.
Lexchin J; Bero LA; Davis C; Gagnon MA
BMJ; 2021 Mar; 372():n370. PubMed ID: 33687982
[No Abstract] [Full Text] [Related]
17. Industry sponsorship in research and publishing: who is really to blame for perceived bias?
Amsden GW
Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974
[No Abstract] [Full Text] [Related]
18. Financial disclosure for review authors.
Nat Neurosci; 2003 Oct; 6(10):997. PubMed ID: 14513027
[No Abstract] [Full Text] [Related]
19. Implications of pharmaceutical industry funding on clinical research.
Lexchin JR
Ann Pharmacother; 2005 Jan; 39(1):194-7. PubMed ID: 15562137
[TBL] [Abstract][Full Text] [Related]
20. Editorial policies on financial disclosure.
Carroll BJ; Rubin RT
Nat Neurosci; 2003 Oct; 6(10):999-1000; author reply 1000-1. PubMed ID: 14513028
[No Abstract] [Full Text] [Related]
[Next] [New Search]
